Clinical trial
This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With…
NCT00059722 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00059722 |
|---|---|
| Title | This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC. |
| Official title | A Phase II, Randomized Double-blind, 2-part, Multicenter Study to Compare the Efficacy of ZD6474 With the Efficacy of ZD1839 (Iressa™) in Subjects With Locally Advanced or Metastatic (IIIB/IV) Non-small Cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy and to Assess the… |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | ZD6474, Placebo, ZD1839 |
| Enrollment | 160 |
| Start date | May 1, 2003 |
| Completion | Jun 1, 2007 |
| First posted | May 5, 2003 |
| Last update posted | Aug 24, 2016 |
| Countries | Argentina, Belgium, Germany, South Africa, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: